MedTrace Logo

A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins

NCT01372631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 218

Last updated 2021-02-10

No results posted yet for this study

Summary

The goal of this research is to further develop novel optical assay systems for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens.

Conditions

Interventions

DEVICE

miniature spectral imaging system

Use of miniature spectral imaging system

DEVICE

Bench-top optical spectrometer

Use of bench-top optical spectrometer

DEVICE

High resolution microendoscope

Use of high resolution microendoscope

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute for Biomedical Imaging and Bioengineering (NIBIB)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • Nimmi Ramanujam, Ph.D. · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2017-04-01
Completion
2017-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372631 on ClinicalTrials.gov